Biotechnologies International

BiotechnologiesInternational, Ltd., a new corporation that owns the rights to over1600 new pharmaceutical products, came to Imaginaria when it was readyto announce itself to the world. It was clear early on that whendealing with such a substantial corporation that seems to appear to thepublic out of nowhere, the main problem is credibility. Imaginariadeveloped a consistent image throughout, from logotype, stationary, andmarketing material designs as well as product and product packagingdesigns that clearly communicate the company's message to the market.